Abstract:Cerebral ischemia (stroke) triggers a complex series of biochemical and molecular mechanisms that impairs the neurologic functions through breakdown of cellular integrity mediated by excitotoxic glutamatergic signalling, ionic imbalance, free-radical reactions, etc. These intricate processes lead to activation of signalling mechanisms involving calcium/calmodulin-dependent kinases (CaMKs) and mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK). The distribution of these transducers bring them in contact with appropriate molecular targets leading to altered gene expression, e.g. ERK and JNK mediated early gene induction, responsible for activation of cell survival/damaging mechanisms. Moreover, inflammatory reactions initiated at the neurovascular interface and alterations in the dynamic communication between the endothelial cells, astrocytes and neurons are thought to substantially contribute to the pathogenesis of the disease. The damaging mechanisms may proceed through rapid nonspecific cell lysis (necrosis) or by active form of cell demise (apoptosis or necroptosis), depending upon the severity and duration of the ischemic insult. A systematic understanding of these molecular mechanisms with prospect of modulating the chain of events leading to cellular survival/damage may help to generate the potential strategies for neuroprotection. This review briefly covers the current status on the molecular mechanisms of stroke pathophysiology with an endeavour to identify potential molecular targets such as targeting postsynaptic density-95 (PSD-95)/N-methyl-d-aspartate (NMDA) receptor interaction, certain key proteins involved in oxidative stress, CaMKs and MAPKs (ERK, p38 and JNK) signalling, inflammation (cytokines, adhesion molecules, etc.) and cell death pathways (caspases, Bcl-2 family proteins, poly (ADP-ribose) polymerase-1 (PARP-1), apoptosis-inducing factor (AIF), inhibitors of apoptosis proteins (IAPs), heat shock protein 70 (HSP70), receptor interacting protein (RIP), etc., besides targeting directly the genes itself. However, selecting promising targets from various signalling cascades, for drug discovery and development is very challenging, nevertheless such novel approaches may lead to the emergence of new avenues for therapeutic intervention in cerebral ischemia.

The complexity of neurobiological processes in acute ischemic stroke

Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Insight into the pathophysiological advances and molecular mechanisms underlying cerebral stroke: current status

Acute ischemic stroke in the clinic and the laboratory Targets for translational research

Molecular Mechanisms of Ischemic Stroke: A Review Integrating Clinical Imaging and Therapeutic Perspectives

Mechanisms of cerebral ischemia: Intracellular cascades and therapeutic interventions

Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies

Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)

Pathogenetic scenarios of the development of brain ischemia and the main elements of the ischemic cascade

Molecular targets in cerebral ischemia for developing novel therapeutics

Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis

Inflammatory mechanisms in ischemic stroke: therapeutic approaches

Pathophysiology of Focal Cerebral Ischemia: a Therapeutic Perspective

Neuroprotective approach in acute ischemic stroke: A systematic review of clinical and experimental studies

Molecular pathophysiological mechanisms of ischemia/reperfusion injuries after recanalization therapy for acute ischemic stroke.

Ischemic stroke: From pathological mechanisms to neuroprotective strategies

The Two Pathophysiologies of Focal Brain Ischemia: Implications for Translational Stroke Research

Ischemic Stroke: Pathophysiology and Evolving Treatment Approaches

The neurovascular unit and systemic biology in stroke - implications for translation and treatment